{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:16:18Z","timestamp":1753877778733,"version":"3.41.2"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,13]]},"DOI":"10.1093\/sleep\/zsab292","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T10:08:20Z","timestamp":1655114900000},"source":"Crossref","is-referenced-by-count":0,"title":["Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al"],"prefix":"10.1093","volume":"45","author":[{"given":"Franck","family":"Skobieranda","sequence":"first","affiliation":[{"name":"Clinical Development, Neuroscience, Jazz Pharmaceuticals , Philadelphia, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Candler","sequence":"additional","affiliation":[{"name":"US Medical Affairs, Neuroscience, Jazz Pharmaceuticals , Philadelphia, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Macfadden","sequence":"additional","affiliation":[{"name":"Global Medical Affairs, Neuroscience, Jazz Pharmaceuticals , Philadelphia, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"2023120718243454900_CIT0001","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab072.488","article-title":"Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy","author":"Kushida","year":"2021","journal-title":"Sleep."},{"volume-title":"Xyrem\u00ae (Sodium Oxybate) Oral Solution, CIII [Prescribing Information]","year":"2020","key":"2023120718243454900_CIT0002"},{"volume-title":"Xywav\u00ae (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution, CIII [Prescribing Information]","year":"2021","key":"2023120718243454900_CIT0003"},{"key":"2023120718243454900_CIT0004","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","author":"U.S. Xyrem Multicenter Study Group","year":"2002","journal-title":"Sleep."},{"key":"2023120718243454900_CIT0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.sleep.2019.06.017","article-title":"Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis","volume":"64","author":"Xu","year":"2019","journal-title":"Sleep Med."},{"key":"2023120718243454900_CIT0006","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","article-title":"A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy","volume":"1","author":"Xyrem International Study Group","year":"2005","journal-title":"J Clin Sleep Med."},{"issue":"7","key":"2023120718243454900_CIT0007","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"Sleep."},{"key":"2023120718243454900_CIT0008","doi-asserted-by":"crossref","first-page":"zsaa206","DOI":"10.1093\/sleep\/zsaa206","article-title":"Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy","volume":"44","author":"Bogan","year":"2021","journal-title":"Sleep."},{"year":"2021","author":"U. S. Food and Drug Administration. Clinical Superiority Findings","key":"2023120718243454900_CIT0009"}],"container-title":["SLEEP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/45\/6\/zsab292\/54092426\/zsab292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/45\/6\/zsab292\/54092426\/zsab292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T22:37:03Z","timestamp":1701988623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsab292\/6604298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":9,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2022,6,13]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsab292","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"type":"print","value":"0161-8105"},{"type":"electronic","value":"1550-9109"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,6,1]]},"article-number":"zsab292"}}